REal-life ON PARKinson's - ITaly (REONPARK-IT)

NCT07403799 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Opicapone 50 mg

Sponsor

Bial - Portela C S.A.